NATHAN ROSSO: Open Payments
NPI 1750808341 · ODESSA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,156 in 229 payments from 19 companies in 2025. Trend: 2023 $5,141 · 2024 $5,001 · 2025 $5,156
Food & beverage: $4,664Education: $491
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $751 |
| UCB, Inc. | 23 | $729 |
| Janssen Biotech, Inc. | 27 | $633 |
| Arcutis Biotherapeutics, Inc. | 27 | $550 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 17 | $488 |
| Novartis Pharmaceuticals Corporation | 19 | $318 |
| Regeneron Healthcare Solutions, Inc. | 12 | $309 |
| Lilly USA, LLC | 12 | $254 |
| E.R. Squibb & Sons, L.L.C. | 10 | $197 |
| Galderma Laboratories, L.P. | 13 | $178 |
Products named: Bimzelx, TREMFYA, Zoryve, SKYRIZI, DUPIXENT, ILUMYA, COSENTYX, TALTZ.
Industry payments across TX — which companies pay providers there.
